Patents by Inventor Zhixing Wu

Zhixing Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220096485
    Abstract: Functionalized pyrano[2,3-d]pyrimidin-7-one derivatives, methods for making the derivatives, and methods of using the derivatives as protein kinase inhibitors.
    Type: Application
    Filed: October 5, 2021
    Publication date: March 31, 2022
    Applicant: The Texas A&M University System
    Inventors: Dai Lu, Chang-Jiang Qiao, Boqiao Fu, Anantha Lakshmi Duddupudi, Zhixing Wu
  • Patent number: 11136333
    Abstract: Functionalized pyrano[2,3-d]pyrimidin-7-one derivatives, methods for making the derivatives, and methods of using the derivatives as protein kinase inhibitors.
    Type: Grant
    Filed: May 23, 2017
    Date of Patent: October 5, 2021
    Assignee: The Texas A&M University System
    Inventors: Dai Lu, Chang-Jiang Qiao, Boqiao Fu, Anantha Lakshmi Duddupudi, Zhixing Wu
  • Publication number: 20190389874
    Abstract: Functionalized pyrano[2,3-d]pyrimidin-7-one derivatives, methods for making the derivatives, and methods of using the derivatives as protein kinase inhibitors.
    Type: Application
    Filed: May 23, 2017
    Publication date: December 26, 2019
    Applicant: The Texas A&M University System
    Inventors: Dai Lu, Chang-Jiang Qiao, Boqiao Fu, Anantha Lakshmi Duddupudi, Zhixing Wu
  • Publication number: 20190092781
    Abstract: Disclosed herein, in part, are fumagillol compounds and methods of use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making fumagillol compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.
    Type: Application
    Filed: November 21, 2018
    Publication date: March 28, 2019
    Inventors: Robert Zahler, Zhenwei Cai, Zhixing Wu, James E. Vath
  • Publication number: 20190023716
    Abstract: Disclosed herein, in part, are fumagillol compounds and methods of use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making fumagillol compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.
    Type: Application
    Filed: March 15, 2018
    Publication date: January 24, 2019
    Inventors: Robert Zahler, Zhenwei Cai, Zhixing Wu, James E. Vath
  • Publication number: 20180237449
    Abstract: Disclosed herein, in part, are fumagillol compounds and methods of use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making fumagillol compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.
    Type: Application
    Filed: August 11, 2016
    Publication date: August 23, 2018
    Inventors: Robert Zahler, Zhenwei Cai, Zhixing Wu, James E. Vath
  • Patent number: 9944613
    Abstract: Disclosed herein, in part, are fumagillol compounds and methods of use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making fumagillol compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: April 17, 2018
    Assignee: Zafgen, Inc.
    Inventors: Robert Zahler, Zhenwei Cai, Zhixing Wu, James E. Vath
  • Publication number: 20180079737
    Abstract: Disclosed herein, in part, are fumagillol compounds and methods of use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making fumagillol compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.
    Type: Application
    Filed: November 30, 2017
    Publication date: March 22, 2018
    Inventors: Robert Zahler, Zhenwei Cai, Zhixing Wu, James E. Vath